Inventor · disambiguated record
Rene Alvarez
Also filed as: ALVAREZ RENE
6 granted patents·19 pending applications·152 citations·filing 2002–2025
86Inventor score
Files withALNYLAM PHARMACEUTICALS INC16ANDO YUKIO2SAH DINAH WEN-YEE2MEYERS RACHEL1SOUTHERN FOLGER DETENTION EQUIPMENT COMPANY1
Top patents by PatentIndex Score
25 records- 0198US8168775B2Compositions and methods for inhibiting expression of transthyretinSAH DINAH WEN-YEE·Filed 2009·Granted May 1, 2012·84 cites·23 claims
- 0295US8741866B2Compositions and methods for inhibiting expression of transthyretinSAH DINAH WEN-YEE·Filed 2012·Granted Jun 3, 2014·29 cites·30 claims
- 0394US9234196B2Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·18 cites·37 claims
- 0491US10240152B2Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·6 cites·53 claims
- 0584US6605283B1Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein geneUS AGRICULTURE·Filed 2002·Granted Aug 12, 2003·15 cites·3 claims
- 0683US12227744B2Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Feb 18, 2025·0 cites·11 claims
- 0777US2025376682A1Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0874US2020283766A1Compositions and Methods for Inhibiting Expression of TransthyretinALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0973US2020199592A1siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1069US2019309293A1Compositions and Methods for Inhibiting Expression of TransthyretinALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1167US2010168205A1Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA MoleculesALNYLAM PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1262US2023340473A1Sirna therapy for transthyretin (ttr) related ocular amyloidosisALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1360US2016264963A1Compositions and Methods for Inhibiting Expression of TransthyretinALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1459US2018171332A1siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisALNYLAM PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1558US2020088746A1Quantification of transthyretin and its isoformsALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1656US2017096663A1siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisALNYLAM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1755US2017045536A1Quantification of transthyretin and its isoformsALNYLAM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1854US2014323541A1Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA MoleculesMEYERS RACHEL·Filed 2012·Application pending·0 cites
- 1954US2015337311A1Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA MoleculesALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2053US2013281510A1siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisANDO YUKIO·Filed 2011·Application pending·0 cites
- 2152US2014315231A1Quantification of transthyretin and its isoformsALNYLAM PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2252US2016076029A1siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisANDO YUKIO·Filed 2015·Application pending·0 cites
- 2339US2004241689A1Antigens of and antibodies to translocated molecules of microorganisms and uses thereofFiled 2002·Application pending·0 cites
- 2438US2014035301A1Strike with Ejector PlateSOUTHERN FOLGER DETENTION EQUIPMENT COMPANY·Filed 2013·Application pending·0 cites
- 2538US2007092870A1Detection of biomoleculesZHAO YIPING·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rene Alvarez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →